[Cutaneous manifestations during treatment with TNF-alpha blockers: 11 cases]

D Lebas1, D Staumont-Sallé, E Solau-Gervais

  • 1Clinique de Dermatologie, Hôpital Claude Huriez, CHRU Lille, Lille Cedex.

Abstract

Insights

Tumor necrosis factor-alpha (TNFα) blockers can cause various skin reactions. Dermatologists should monitor patients for these potential adverse dermatological effects during treatment.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Context:

  • Tumor necrosis factor-alpha (TNFα) blockers are increasingly used in dermatology.
  • Adverse dermatological effects of TNFα blockers are not well-documented.
  • Understanding these side effects is crucial for patient safety.

Purpose:

  • To report the spectrum of cutaneous adverse events observed in patients treated with TNFα blockers.
  • To raise awareness among dermatologists regarding potential skin reactions.

Summary:

  • A retrospective study identified eleven patients experiencing cutaneous reactions while on TNFα blockers.
  • Observed reactions included lupus syndrome, vasculitis, pustulosis, psoriasis, atopic dermatitis, lichenoid rash, purpuric capillaritis, and melanoma.
  • Delayed skin rash was also noted.

Impact:

  • Highlights the diverse range of potential dermatological side effects associated with TNFα blockers.
  • Emphasizes the need for dermatologists to be vigilant for these adverse reactions.
  • Suggests further research into physiopathological mechanisms and prospective studies for better management.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...